NRNematollah Rostami

Nematollah Rostami

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nematollah Rostami has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Mahbobeh Mashayekhi

    Shahid Beheshti Univ Med Sci, Modarres Hosp, Dept Endocrinol, Tehran, Iran

    1 shared publication
  • Mahyar Khaledi

    Department of Internal Medicine, Semnan University of Medical Sciences, Semnan, Iran

    1 shared publication
  • Maryam Tohidi

    Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran

    1 shared publication
  • Sarvin Alizadeh Sadighi

    Shahid Beheshti Univ Med Sci, Modarres Hosp, Clin Res Dev Ctr, Dept Internal Med, Tehran, Iran

    1 shared publication
  • Soheila Borhani

    Department of Internal Medicine, Semnan University of Medical Sciences, Semnan, Iran

    1 shared publication

Latest Publications

  • Open Access

    Insulin-like growth factor (IGF) levels in pre-treatment plasma identifying breast cancer: A case control study

    by Sarvin Alizadeh Sadighi, Nematollah Rostami, Maryam Tohidi, Mahbobeh Mashayekhi

    Background: Diabetes (primarily type 2) is linked to a higher risk of breast cancer. Insulin-like growth factor (IGF) is one of the most important factors that affects mitosis and thus inhibits apoptosis. The purpose of this study was to compare the pre-treatment insulin-like growth factor (IGF) levels in breast cancer against normal population. Methods: In this case-control study, 60 patients with breast cancer and 60 healthy controls were enrolled in 2017 and 2018 at Tehran's Shahid-Modarres Hospital. In this study, the blood sugar of the patients was examined before entering the study, and the age of the patients was also within the age limit of 18 to 70 years. They were studied to determine the relationship between insulin-like growth factor (ELISA method) and breast cancer. Results: Both groups have similar IGF-1 levels (Ctrl and Case) (P= 0.188). But, IGF-2 levels were significantly higher in breast cancer patients (373.4 vs. 317.3 ng/ml), (P=0.0001). Conclusion: According to our study, IGF-2 may serve as a prognostic biomarker and potential therapeutic target for breast cancer. However, further investigation is needed to validate this claim.


  • Clinical Significance of Positive Platelet Immunofluorescence Assay in Adult Immune Thrombocytopenia

    by Nematollah Rostami, Soheila Borhani, Mahyar Khaledi

    Immune thrombocytopenia (ITP) is a relatively common hematologic disorder manifested by low platelet count due to immune-mediated platelet destruction and/or suppression of platelet production. This study aim was to evaluate characteristics and clinical presentation of adult patients with ITP and exploring the clinical value of platelet antibodies assay in proposed cases in Iranian population. In this prospective case series 46 adult patients with ITP and platelet count of 9/L, referred to the Taleghani Medical Center, Tehran, Iran between 2007 and 2009 were evaluated. There were 26 females and 20 males (1.3:1) with mean age of 38.9 ± 19.7 years. The platelet autoantibodies were measured by means of indirect platelet suspension immunofluorescence test. According to our results, 7 patients (15.2 %) displayed a positive platelet antibody assay. There was a significant negative correlation between platelet count and antibody level (r = −0 0.59; p < 0.001). Additionally, a positive correlation between platelet count and patients’ age (r = 0.302; p = 0.042) was detected. 20 patients (56.5 %) were symptomatic at presentation and the most common bleeding signs were petechia, purpura and epistaxis. Results indicated no significant correlation between increased platelet antibody level and bleeding manifestations except for hematuria (r = 0.435; p = 0.02) and epistaxis (r = 0.382; p = 0.015). Disclosure of platelet autoantibodies and the consequential thrombocytopenia associated to some extent but not completely with the propensity to bleed which necessitates more factors to be evaluated.